GE HealthCare Technologies Inc. (GEHC)
NasdaqGS · Price as of · Nasdaq Real Time Price
- Profitability13/20
Profitable but shrinking: $1.91B over the last four reported quarters, down from $2.48B the year before.
- Insider buying vs selling20/20
Insiders are net buyers: 2 open-market buys worth $742,165 vs 0 sells worth $0 across the last 20 Form 4 filings.
- Dilution and offerings11/15
Share count down 0.7% in a year with 2 offering-related filings. Mild dilution.
- Analysts20
- Implied upside+15.8%
- Target range$70.00 to $96.00
- EPS expected$1.20 +13%
- A year ago$1.07
- Revenue expected$5.35B +4.1%
- Estimate range$1.16 to $1.25
GEHC closed at $71.42 on Oct 22, up 8.1% since Sep 23. Chart read: price above both the 50-day and 200-day moving averages; the 50-day is below the 200-day (downtrend structure); trading at 42% of the 52-week range ($59.49 to $88.16).
Insider buying and selling at GE HealthCare Technologies Inc. (GEHC)
The most recent Form 4 on record for GE HealthCare Technologies Inc. (GEHC) is May 22, 2026, when Kevin Lobo, Director, bought $641,800 of stock. An open-market purchase is money the filer chose to put in.
| Insider | Action | Value | Date | Type |
|---|---|---|---|---|
| Kevin Lobo · Director | Buy | $641,800 | May 22, 2026 | Notable buy |
| H Lawrence Culp Jr · Director | Buy | $5.0M | May 6, 2026 | Notable buy |
| James Saccaro · Chief Financial Officer | Buy | $200,585 | May 1, 2026 | Notable buy |
| Peter J Arduini · President and CEO | Buy | $249,827 | April 30, 2026 | Notable buy |
| Frank R Jimenez · GC & Corporate Secretary | Buy | $105,788 | April 30, 2026 | Notable buy |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 8-K | September 22, 2026 | 8-K |
| 4 | September 16, 2026 | FORM 4 |
| 3 | September 16, 2026 | FORM 3 |
| 4 | September 4, 2026 | FORM 4 |
| 4 | September 4, 2026 | FORM 4 |
| 4 | September 4, 2026 | FORM 4 |
| 4 | September 4, 2026 | FORM 4 |
| 4 | September 4, 2026 | FORM 4 |
Articles that mention GE HealthCare Technologies without it being the main subject.
Frequently asked questions
When does GEHC report earnings?
GE HealthCare Technologies Inc. (GEHC) is scheduled to report quarterly results on October 28, 2026, before the open. The 18-analyst consensus is $1.20 per share on revenue of $5.35B for the quarter ended September 30, 2026, against $1.07 and $5.14B a year earlier. It has beaten the consensus EPS estimate in 3 of the last four quarters.
What do analysts expect for GEHC?
20 analysts cover GE HealthCare Technologies Inc. (GEHC). The consensus rating is Buy. The average price target is $82.70, in a range of $70.00 to $96.00.
Are insiders buying or selling GEHC?
We track Form 4 filings for GE HealthCare Technologies Inc. (GEHC). The activity listed on this page shows 5 open-market purchases. Each row is labelled Routine when the filer declared a pre-arranged 10b5-1 plan, Tax withholding when shares were sold automatically to cover the tax on a vest, or Own call when neither applies.
Where can I see GEHC SEC filings?
Recent filings are listed on this page, newest first. The latest is an 8-K filed September 22, 2026.